Xiankai B. Chen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Standardized sarcopenia assessment should be incorporated into prognosis analysis of esophageal cancers: a prospective cohort study lasting 8 years.
Journal: Frontiers in nutrition
Published: April 26, 2026
Highlighting sarcopenia management in cancer treatments: evidence from umbrella meta-analysis.
Journal: Frontiers in nutrition
Published: March 16, 2026
Validation and refinement of the AJCC 8th edition ypStage in esophageal squamous cell carcinoma after neoadjuvant therapy: a large-scale retrospective cohort study.
Journal: International journal of surgery (London, England)
Published: September 30, 2025
Tumor microenvironment and immune-related myositis: addressing muscle wasting in cancer immunotherapy.
Journal: Frontiers in immunology
Published: February 20, 2025
Single-cell atlas of the esophageal squamous cell carcinoma immune ecosystem to predict immunotherapy response.
Journal: Signal transduction and targeted therapy
Published: January 14, 2025
Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma.
Journal: Thoracic cancer
Published: November 13, 2024
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study.
Journal: Cancer biology & therapy
Published: October 27, 2024
Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma.
Journal: Thoracic cancer
Published: September 22, 2024
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: May 16, 2024
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 17, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.
Journal: Nature medicine
Published: March 29, 2024
Unveiling the detrimental vicious cycle linking skeletal muscle and COVID-19: A systematic review and meta-analysis.
Journal: Journal of evidence-based medicine
Published: January 02, 2024
Last Updated: 09/26/2026